A new study by the Alzheimer’s Society of Canada found that more than one million Canadians could be living with dementia by 2030, potentially tripling the nearly 600,000 currently diagnosed by 2050.
- Experimental Alzheimer’s drug slows disease, researchers say. Will it make a difference?
- Alzheimer’s drug shows signs of slowing disease in early results of global study
- Nova Scotians with dementia could spike by almost 90% by 2050, study warns